Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov;29(6):1490-1498.
doi: 10.1111/hae.14857. Epub 2023 Sep 17.

Evaluation of the care pathway in the context of the dispensing of emicizumab (Hemlibra) in community and hospital pharmacies in France: A patient satisfaction survey

Valérie Chamouard  1   2   3 , Julie Freyssenge  4 , Gaetan Duport  5 , Fabienne Volot  6 , Rémi Varin  3   7 , Nicolas Giraud  5 , Yesim Dargaud  1   8 , Laurie Fraticelli  9
Affiliations

Evaluation of the care pathway in the context of the dispensing of emicizumab (Hemlibra) in community and hospital pharmacies in France: A patient satisfaction survey

Valérie Chamouard et al. Haemophilia. 2023 Nov.

Abstract

Introduction: Since June 2021 in France, patients with haemophilia A with anti-factor VIII inhibitors and patients with severe haemophilia A without anti-factor VIII inhibitors, and treated with emicizumab (Hemlibra), have to choose the dispensing circuit community or hospital pharmacy.

Aim: To evaluate satisfaction of patients whether they choose dispensation from a community pharmacy or retained dispensation from the hospital pharmacy, to understand the main motivation for choosing the community or the hospital pharmacy.

Methods: All patients living in France, regardless of age, were eligible to participate. Between September 13, 2022, and January 9, 2023, 175 respondents answered the satisfaction survey, including 123 in community pharmacy and 52 in hospital pharmacy.

Results: Eighteen months after availability in community pharmacies, treatment accessibility is improved for the benefit of the patient. The door-to-door travel times are significantly reduced to the community pharmacy with an average gain of 16.5 min saved from the place of residence. Patients are mostly satisfied with the new dispensing circuit especially concerning the overall satisfaction (p < .0001), the travel time (p < .0001) and the strong relationship with the pharmacist (p = .0022) compared to hospital pharmacy.

Conclusion: Innovation in care pathways is showing its full potential in improving access to medication, made possible by the implementation of a rigorous organization accompanied by training to enable healthcare professionals involved in primary care to provide appropriate management.

Keywords: community pharmacy services; emicizumab; haemophilia A; health services accessibility; patient satisfaction.

PubMed Disclaimer

References

REFERENCES

    1. Beny K, du Sartz de Vigneulles B, Carrouel F, et al. Haemophilia in France: modelisation of the clinical pathway for patients. IJERPH. 2022;19(2):646.
    1. Schwartz CE, Stark RB, Michael W, Rapkin BD. Understanding haemophilia caregiver burden: does appraisal buffer the impact of haemophilia on caregivers over time? Psychol Health. 2020;35(12):1516-1530.
    1. Coppola A, Cerbone AM, Mancuso G, Mansueto MF, Mazzini C, Zanon E. Confronting the psychological burden of haemophilia. Haemophilia. 2011;17(1):21-27.
    1. Brown LJ, La HA, Li J, Brunner M, Snoke M, Kerr AM. The societal burden of haemophilia A. I - A snapshot of haemophilia A in Australia and beyond. Haemophilia. 2020;26(Suppl 5):3-10.
    1. Chamouard V, Fraticelli L, Freyssenge J, et al. PHAREO study: perceived and observed accessibility to therapeutic drugs used for treating patients with inherited bleeding disorders. J Clin Pharm Ther. 2022;47(10):1667-1675.

LinkOut - more resources